Intravenous monoclonal antibody infusion targeting epidermal growth factor receptor in colorectal cancer therapy. Administered in outpatient oncology centers and infusion suites. Supplied through oncology-focused pharmaceutical networks to healthcare providers and facilities for procurement in metastatic disease management protocols.